Emerson Electric Co.(EMR)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
EMR | 89.50 B | 35.66x | 7.00% | 13.83% | $4.50 | 12.80% | 0.68x | 1.35% | $166.35 | $122.64 |
3665.TW | 375.53 B | 39.27x | 37.50% | 12.90% | $49.02 | 24.66% | 0.36x | 0.74% | $2983.85 | $1095.40 |
VRT | 78.37 B | 49.05x | 24.10% | 15.09% | $4.15 | 43.94% | 0.70x | 0.08% | $379.76 | $147.72 |
AME | 56.71 B | 36.70x | 15.00% | 20.04% | $6.74 | 14.56% | 0.21x | 0.52% | $260.78 | $181.76 |
ROK | 47.60 B | 40.90x | 7.90% | 13.39% | $10.46 | 30.63% | 1.03x | 1.29% | $495.83 | $339.27 |
Peer Valuation & Performance Analysis
Peer group analysis for Emerson Electric Co. (EMR) compared to its primary competitors (including 3665.TW, VRT, AME) reveals distinct metrics. EMR trades at a valuation discount relative to its competitors, with a P/E ratio of 35.7x versus the peer average of 41.5x (representing a 14% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, EMR's revenue growth of 7.0% lags behind the peer average of 21.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 13.8% is comparable to the peer average of 15.4%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• EMR ranks #1 in P/E ratio, #5 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $161.59 | $165.01 | $161.06 | $163.11 | 3,823,475 | +1.65% |
| 2026-10-20 | $158.28 | $161.13 | $156.82 | $160.46 | 2,994,700 | -0.05% |
| 2026-10-19 | $163.44 | $163.51 | $160.09 | $160.54 | 2,607,900 | -0.58% |
| 2026-10-16 | $161.40 | $164.09 | $159.30 | $161.47 | 3,425,400 | -0.42% |
| 2026-10-15 | $160.17 | $162.23 | $156.71 | $162.15 | 2,548,000 | +0.66% |
| 2026-10-14 | $162.12 | $163.19 | $159.25 | $161.08 | 2,769,300 | -1.48% |
| 2026-10-13 | $162.17 | $163.69 | $160.50 | $163.50 | 2,131,700 | +0.64% |
| 2026-10-12 | $161.79 | $163.85 | $161.28 | $162.46 | 2,313,900 | +0.39% |
| 2026-10-09 | $160.37 | $162.32 | $158.88 | $161.83 | 2,555,700 | +1.74% |
| 2026-10-08 | $157.93 | $159.66 | $156.25 | $159.06 | 2,374,400 | -0.10% |
| 2026-10-07 | $158.35 | $161.55 | $157.59 | $159.22 | 3,039,800 | -1.35% |
| 2026-10-06 | $163.25 | $165.24 | $161.15 | $161.40 | 2,856,100 | -0.57% |
| 2026-10-05 | $161.74 | $164.21 | $160.99 | $162.33 | 2,139,300 | +0.45% |
| 2026-10-02 | $161.59 | $164.13 | $160.24 | $161.61 | 2,900,600 | +1.92% |
| 2026-10-01 | $153.35 | $159.18 | $153.10 | $158.57 | 3,341,400 | +2.24% |
Explore More Analysis for EMR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.